Cargando…

Cinobufacini Injection Inhibits the Proliferation of Triple-Negative Breast Cancer Through the Pin1–TAZ Signaling Pathway

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer (BC), which is characterized by the total absence of human epidermal growth factor receptor 2 (HER2), progesterone receptor (PR), and estrogen receptor (ER) expression. Cinobufacini injection (CI) is the aqueous extract f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Lu, Liu, Xu, Yu, Bing, Yuan, Ye, Zhao, Qianru, Chen, Yuru, Qu, Bin, Du, Xue, Tian, Xiaoxuan, Shao, Rui, Wang, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016199/ https://www.ncbi.nlm.nih.gov/pubmed/35450041 http://dx.doi.org/10.3389/fphar.2022.797873

Ejemplares similares

Cinobufacini injection suppresses the proliferation of human osteosarcoma cells by inhibiting PIN1-YAP/TAZ signaling pathway
por: Chen, Yuru, et al.
Publicado: (2023)

Comparative Pharmacokinetics of Cinobufacini Capsule and Injection by UPLC-MS/MS
por: Li, Ming, et al.
Publicado: (2022)

Treatment of Huge Hepatocellular Carcinoma Using Cinobufacini Injection in Transarterial Chemoembolization: A Retrospective Study
por: Dong, Jun, et al.
Publicado: (2016)

Cinobufacini Injection Improves the Efficacy of Chemotherapy on Advanced Stage Gastric Cancer: A Systemic Review and Meta-Analysis
por: Zhang, Xing, et al.
Publicado: (2018)

SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast Cancer
por: Liu, Peng, et al.
Publicado: (2018)

Cinobufacini ameliorates experimental colitis via modulating the composition of gut microbiota
por: Bai, Yongfeng, et al.
Publicado: (2019)

Association Between BRCA Status and Triple-Negative Breast Cancer: A Meta-Analysis
por: Chen, Haixia, et al.
Publicado: (2018)

Current landscape of personalized clinical treatments for triple-negative breast cancer
por: Zhang, Jun, et al.
Publicado: (2022)

Cinobufacini promotes apoptosis of bladder cancer cells by influencing the expression of autophagy-related genes
por: Chen, Dong, et al.
Publicado: (2018)

Dandelion extract inhibits triple-negative breast cancer cell proliferation by interfering with glycerophospholipids and unsaturated fatty acids metabolism
por: Wang, Shan, et al.
Publicado: (2022)

Cinobufacini Inhibits the Development of Pancreatic Cancer Cells through the TGFβ/Smads Pathway of Pancreatic Stellate Cells
por: Li, Quan-Wang, et al.
Publicado: (2022)

Hypoxia Triggers TAZ Phosphorylation in Basal A Triple Negative Breast Cancer Cells
por: Liu, Qiuyu, et al.
Publicado: (2022)

TAZ Induces Migration of Microglia and Promotes Neurological Recovery After Spinal Cord Injury
por: Hu, Xuyang, et al.
Publicado: (2022)

PIN1 in Cell Cycle Control and Cancer
por: Cheng, Chi-Wai, et al.
Publicado: (2018)

Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers
por: Soyama, Hirotoshi, et al.
Publicado: (2022)

Editorial: Targeting triple negative breast cancer by natural compounds
por: Kumar, Shashank, et al.
Publicado: (2023)

Network Pharmacology–Based Identification of Key Mechanisms of Xihuang Pill in the Treatment of Triple-Negative Breast Cancer Stem Cells
por: Zhang, Yu-Zhu, et al.
Publicado: (2021)

Corrigendum: TAZ induces migration of microglia and promotes neurological recovery after spinal cord injury
por: Hu, Xuyang, et al.
Publicado: (2022)

Structure-Based Design of 2-Aminopurine Derivatives as CDK2 Inhibitors for Triple-Negative Breast Cancer
por: Liang, Hanzhi, et al.
Publicado: (2022)

Dezocine, An Opioid Analgesic, Exerts Antitumor Effects in Triple-Negative Breast Cancer by Targeting Nicotinamide Phosphoribosyltransferase
por: Xue, Chenyang, et al.
Publicado: (2021)

Target Analysis and Mechanism of Podophyllotoxin in the Treatment of Triple-Negative Breast Cancer
por: Zhang, Wenfeng, et al.
Publicado: (2020)

Meta-Analysis of Therapy of Cinobufacini Capsule Adjunct with First-Line Platinum-Based Chemotherapy for the Treatment of Advanced NSCLC
por: Peng, Wenpan, et al.
Publicado: (2021)

Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy
por: Vici, Patrizia, et al.
Publicado: (2016)

Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway
por: Yang, Ting, et al.
Publicado: (2021)

A Guide to PIN1 Function and Mutations Across Cancers
por: El Boustani, Maguie, et al.
Publicado: (2019)

Small molecules targeting Pin1 as potent anticancer drugs
por: Zhang, Jing, et al.
Publicado: (2023)

Effect of Bicalutamide on the proliferation and invasion of human triple negative breast cancer MDA-MB-231 cells
por: Kong, Yan, et al.
Publicado: (2020)

Is There an Epigenetic Component Underlying the Resistance of Triple-Negative Breast Cancers to Parp Inhibitors?
por: Lovato, Amanda, et al.
Publicado: (2012)

Focus on Triple-Negative Breast Cancer: Potassium Channel Expression and Clinical Correlates
por: Lastraioli, Elena
Publicado: (2020)

Metabolomic Impact of Lidocaine on a Triple Negative Breast Cancer Cell Line
por: Chamaraux-Tran, Thiên-Nga, et al.
Publicado: (2022)

Palmatine Attenuates Metastatic Lung Colonization of Triple Negative Breast Cancer Cells
por: Ativui, Selase, et al.
Publicado: (2022)

Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
por: Tian, Hao, et al.
Publicado: (2021)

Bioluminescence Imaging-Based Assessment of the Anti-Triple-Negative Breast Cancer and NF-Kappa B Pathway Inhibition Activity of Britanin
por: Xu, Xinyi, et al.
Publicado: (2020)

Heterogeneity and potential therapeutic insights for triple-negative breast cancer based on metabolic‐associated molecular subtypes and genomic mutations
por: Li, Lijuan, et al.
Publicado: (2023)

Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer
por: Zhao, Wenjie, et al.
Publicado: (2021)

Adverse events of bevacizumab for triple negative breast cancer and HER-2 negative metastatic breast cancer: A meta-analysis
por: Xun, Xueqiong, et al.
Publicado: (2023)

RNAi screens for Rho GTPase regulators of cell shape and YAP/TAZ localisation in triple negative breast cancer
por: Pascual-Vargas, Patricia, et al.
Publicado: (2017)

AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2018)

Maackiain Modulates miR-374a/GADD45A Axis to Inhibit Triple-Negative Breast Cancer Initiation and Progression
por: Peng, Fu, et al.
Publicado: (2022)

Efficacy and safety of PD-1 and PD-L1 inhibitors combined with chemotherapy in randomized clinical trials among triple-negative breast cancer
por: Qi, Yihang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_catolam8d32e3ta41het79g36c